To mark World Obesity Day 2025, Novo Nordisk participated in the Chula Obesity Day event, organised by Chulalongkorn University. As part of the session 'How Cities and Partnerships Drive a Sustainable ...

De nordiska börserna inledde veckans handel med uppgångar på samtliga huvudindex och fortsatte i linje med förra veckans ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...

NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The respiratory segment, often influenced by seasonal factors, registered a 1.1% increase in value but faced a 4.6% decline ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

M&T Bank Corp lessened its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 3.0% during the 4th ...

Assetmark Inc. grew its holdings in First Trust Enhanced Short Maturity ETF (NASDAQ:FTSM – Free Report) by 71.5% during the fourth quarter, according to the company in its most recent Form 13F filing ...

New trial data showed the drug helped obese or overweight type 2 diabetics lose an average 15.7% of their weight, when an ...

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...